Thus, our work showed for the first time that TTF-1-promoter-operating miR-7 expression might be an ideal strategy for targeted expression of miR-7 in lung cancer, which provides preliminary experimental basis for targeted expression of distinct miRNAs in lung cancer and was helpful for the development of gene therapy against clinical lung cancer. The gene discussed is TTF1; the disease is lung cancer.